Walk Around the World for Brain Tumours
(1 Jan to 5 Nov 2011)
and the

International Brain Tumour Awareness Week
(30 Oct to 5 Nov 2011)

Greater Collaboration     Greater Knowledge       Greater Hope

www.theibta.org

 


Search the IBTA website.
Enter search terms:

IBTA Formation


MEDIA RELEASE :

International brain tumour advocacy group established
Before the meeting commenced. Canadian participants on the left. Irish in the front.
Edinburgh (UK) – Tuesday 10 May 2005

(This was the media release distributed after the Edinburgh meeting.)


"An international advocacy organisation (IBTA) for the support of brain tumour patients and carers was formed during a major neuro-oncology conference held at Edinburgh (UK) last week.

A group of brain tumour patients, carers and health professionals, including researchers, scientists, nurses and clinicians who work in the area, met during the joint conference of the World Federation of Neuro Oncology and the European Association for Neuro Oncology and established the International Brain Tumour Alliance (IBTA).


The advocacy meeting was attended by fifty people representing eleven countries from Europe, North America, Asia, the Middle East and Oceania.

The new group seeks to achieve a wider public understanding of the specific challenges faced by those living with a central nervous system tumour, their families and carers.

In the developed world more than 50,000 people annually are diaMrs Kathy Oliver (Secretary IBTA) with the group's display at the Edinburgh conference. The display proved to be a means of promoting the IBTA to the 1100 participants and also identifying support development needs in different regional areas where we hope to work in partnership with local people. IBTA is willing to arrange similar displays at other relevant conferences and to make available helpful information brochures for brain tumour patients and carers provided by support groups. At this stage of our development sponsorship will be required for these projects. Alternatively, IBTA can provide - again on a sponsorship basis - a package of material about the IBTA for inclusion in the satchels given to conference participants.gnosed with a malignant primary brain tumour.

Many of the tumours are known as glioblastoma multiforme (GBM) and have a particularly poor prognosis.

It is only in the last twelve months t
hat a breakthrough treatment protocol involving concomitant radiation therapy and a chemotherapy drug called temozolomide has shown some promise of success in treating these tumours.

There are also many other people who suffer from so-called benign brain tumours and lower-grade tumours which can significantly affect their health.

The inaugural meeting appointed Mr Denis Strangman of Canberra, Australia, as its chair and Mrs Kathy Oliver of Surrey, UK, as its secretary. Mr Strangman is chair of Brain Tumour Australia* and became involved as a patient advocate after the death of his wife Margaret from a malignant brain tumour in 2001. (* Mr Strangman, who was the Foundation Chair of BTA during 2003-2005, retired as Chair of BTA in 2005 and now concentrates on the IBTA.)


Leaders and representatives from key brain tumour support, advocacy and information groups in the UK, US, Canada and Australia attended the meeting and support for the new patient and carer initiative has also come from brain tumour groups in Italy, France, Germany, India and Ireland.

The new group seeks to work with clinicians and others to assist people living with a brain tumour and their carers and families.

L-R: Mrs Zoe Hoppe (UK), Mr Denis Strangman (Australia), Mr Tim Downing (Western Australia), Mrs Kathy Oliver (UK). Mr Downing was the returning officer for the closely-contested vote on the organisation's name.It is particularly keen to encourage the establishment of support groups in countries where they do not already exist and will approach industry and cancer agencies for assistance with this work.

In recent years similar international collaborative disease-specific groups
have been established for breast, prostate, and lung cancers.

Contact: Denis Strangman 61 2 6258 3912. e-mail: denis@theibta.org






Among those attending the inaugural meeting were:
Maureen Daniels and Rosemary Cashman (Canadian Alliance of Brain Tumour Organisations), Tim Downing (Australia), Professor Geoff Pilkington (Portsmouth, UK), Dr Rakesh Jalali (Brain Tumour Foundation of India), Alan Gow (Macmillan Cancer Relief, UK), Judy Gordon (carer and mother, Aberdeenshire, UK), Kevin and Marguerite Sciuk (patient, Virginia, USA), Professor John Darling (Wolverhampton, UK), Denis Roth (The Brain Tumor Society, USA), Ibrahim Qaddoumi (Jordan), Virginia Stark-Vance (Author of "100 Questions and Answers about Brain Tumors"), Verena Amberger-Murphy (Scientist, Dublin),  Dr Yutaka Sawamura (Neurosurgeon, Japan), Dr Jun Takahashi (Kyoto, Japan), Mitsuaki Shirahata (Kyoto, Japan), Angela and Neil Dickson (Directors, Samantha Dickson Research Trust, UK), Theresa Hood (nurse specialist), Mario Moro (Italy), Georgina O'Brien (nurse specialist, Oxford), Katie Sheen (SDRT Astro Fund, UK), Hannaeke Zwinkels (Netherlands), Dr David Hamilton (NZ), Sharon Lamb (USA), Mary Hogan, Joan Wynne and Mary O'Loughlin (Brain Tumour Support Group, Ireland).








































































Notes: The intention of the founding meeting that we seek to represent all tumours of the central nervous system. As is the practice in the scientific literature and clinical use, we use the words "brain tumour", not "brain cancer".

Copyright 2007-2009 ©  The International Brain Tumour Alliance [IBTA]. All Rights Reserved.

The IBTA is a not-for-profit, limited liability company incorporated in England and Wales, Company Number: 6031485. The registered address is: c/o Roxburghe House, 273-287 Regent Street, London W1B 2AD, UK. Correspondence should be addressed to the Secretary (details on the Contacts page) not to the registered company address. Click here for the Contacts page.


The IBTA protects users' privacy under the terms of the UK Data Protection Act 1998 and has registered as data controllers with the Information Commissioner's Office.